| ¿ Qué debería definir una infección “irruptiva” del SARS-CoV-2? JS Schieffelin, EB Norton, JK Kolls | | |
| 152: STAT4 negatively regulate hepatocyte survival during auto-immune liver inflammation P Kumar, K Chen, X Zhao, D Pociask, JK Kolls Cytokine 63 (3), 278-279, 2013 | | 2013 |
| 156: IFN-γ and IL-17A drive distinct airway changes in a murine model of steroid-unresponsive severe asthma M Raundhal, C Morse, TB Oriss, A Khare, W Horne, J Kolls, S Wenzel, ... Cytokine 70 (1), 66, 2014 | | 2014 |
| 206 IL-22 binding protein: a potential target for immunomodulation in cystic fibrosis C Bojanowski, L Kikukawa, C Katherine, J Bodnar, S Lee, J Bomberger, ... Journal of Cystic Fibrosis 22, S107, 2023 | | 2023 |
| 208 Impact of corrector treatment on transcriptome analysis of CFBE41ocells cultured on cell culture inserts stably expressing F508del-mutant CFTR R Clark, S Lu, J Kolls Journal of Cystic Fibrosis 22, S108, 2023 | | 2023 |
| 211 Systems serology in cystic fibrosis: anti-Pseudomonas IgG1 responses and reduced lung function S Lu, B Gunn, N Rysavy, K Poch, S Caceres, B Vestal, M Saavedra, ... Journal of Cystic Fibrosis 22, S109, 2023 | | 2023 |
| 269 CRITICAL ROLE OF INTERLEUKIN-17 AND INTERLEUKIN-17 RECEPTOR SIGNALING IN TNBS-INDUCED COLITIS. Z Zhang, M Zheng, J Bindas, P Schwarzenberger, JK Kolls Journal of Investigative Medicine 54 (1), S126, 2006 | | 2006 |
| 274 Anti-CD20 treatment before inhaled vector administration attenuates humoral and cellular immune responses and permits secondary gene transfer R Clark, J Hoffman, F Rabito, F Munyonho, P Remcho, J Kolls Journal of Cystic Fibrosis 22, S138-S139, 2023 | | 2023 |
| 3 IN VIVO AND IN VITRO GENE TRANSFER IN RAT INTESTINAL EPITHELIAL CELLS BY E1-DELETED ADENOVIRAL VECTOR.: Basic Science Young Investigator Award RA Noel, JK Kolls, D Lei, DY Cheng Journal of Pediatric Gastroenterology and Nutrition 23 (3), 343, 1996 | | 1996 |
| 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016 A Lundqvist, V van Hoef, X Zhang, E Wennerberg, J Lorent, K Witt, ... Journal for immunotherapy of cancer 4, 1-106, 2016 | 10 | 2016 |
| 340 Anti-CD20 attenuates lung humoral and cellular immune responses: implications for gene therapy in Cystic Fibrosis R Clark, F Rabito, F Munyonho, P Remcho, JK Kolls Journal of Clinical and Translational Science 8 (s1), 103-103, 2024 | | 2024 |
| 388: System serology of anti-pseudomonas antibodies and lung disease in cystic fibrosis S Lu, B Gunn, J Kolls Journal of Cystic Fibrosis 20, S183-S184, 2021 | | 2021 |
| 424 Systems serology in cystic fibrosis: Anti-Pseudomonas immunoglobulin G1 responses and reduced lung function J Kolls, S Lu, K Chen, K Song, J Pilewski, B Gunn Journal of Cystic Fibrosis 21, S244-S245, 2022 | | 2022 |
| 432 Molecular signatures of human neutrophils from healthy subjects and people with cystic fibrosis Y Hu, C Bojanowski, D Wellems, K Song, C Scull, S Jennings, J Li, J Kolls, ... Journal of Cystic Fibrosis 21, S248, 2022 | | 2022 |
| 514. Potential of Bone Marrow Mesenchymal Stem Cells for Cystic Fibrosis Therapy G Wang, BA Bunnell, RG Painter, S Tom, NA Lanson, JL Spees, ... Molecular Therapy 9 (1), 1, 2004 | | 2004 |
| 581. IL-23 Is Required for B-Cell Memory after CD40 Ligand-Modified Dendritic Cell Vaccination M Zheng, JA Bindas, R Rapaka, JK Kolls Molecular Therapy 13, S224, 2006 | | 2006 |
| 5th ADVANCES AGAINST ASPERGILLOSIS L Romani, WJ Steinbach, R Ben-Ami, E Bignell, JM Vyas, JK Kolls, ... ASPERGILLOSIS, 2012 | | 2012 |
| 605. Cytokine Profile Assessment of Mesothelioma Patients Treated with Escalating Doses of Intrapleurally Administered, Genetically Modified PA1STK Cells and a Twice Daily … PS Byrne, PO Schwarzenberger, L Harrison, J Norton, JK Kolls Molecular Therapy 9 (S1), S229, 2004 | 1 | 2004 |
| 608 Anti-CD20 permits secondary lung gene transfer: implications for gene editing approaches in cystic fibrosis J Kolls, R Clark, J Hoffman, F Rabito, P Remcho Journal of Cystic Fibrosis 21, S337-S338, 2022 | | 2022 |
| 823 EXERCISE SUPPRESSION OF THE HEPATIC TUMOR NECROSIS FACTOR RESPONSE TO LIPOPOLYSACCHARIDE LD Crouch, RE Shepherd, IV Deacluc, JK Kolls, QJ Bagby Medicine & Science in Sports & Exercise 26 (5), S148, 1994 | | 1994 |
